The aqueous infusion (tea) of Stachytarpheta cayennensis leaves is used ethnomedically in Peru, Nigeria and other tropical countries for the management of diabetes. Oral administration (p. o.) of aqueous (125 mg/kg) and methanolic (2000 mg/kg) extracts of the leaves to alloxan-diabetic rats showed significant blood glucose reductions by 43 and 53 %, respectively, at the end of a 4 hour period similar to the strong effect of glibenclamide (5 mg/kg, p. o.). The methanolic extract was successively partitioned into ethyl acetate, butanol and water fractions, and the same test showed that the butanol fraction (2000 mg/kg) had the highest (50 %) hypoglycaemic activity at 4 hours after oral administration. It was also the most active fraction when tested in vitro [insulin release from an insulin secreting cell line (INS-1)] and was also active in normal rats and rats made hyperglycaemic by a glucose load. Its activity was comparable to that of glibenclamide (positive control) in these models. This active butanol fraction was subjected to chromatographic subfractionation; some subfractions reduced hyperglycaemia in alloxan-diabetic rats to 60 and 78 % and induced insulin release from the INS-1 cells; other subfractions, however, gave hyperglycaemic activities in vivo and inhibition of insulin release from the INS-1 cells. Three major compounds of the butanol fraction were isolated and characterised as 6β-hydroxyipolamide, ipolamide and isoverbascoside; they increased insulin secretion from INS-1 cells to 125, 128 and 127 %, respectively, whereas glibenclamide increased insulin secretion to 157 %. The results justify the ethnomedical use of the plant in the management of diabetes and suggest that the butanol fraction and some of its isolated constituents mediate their actions primarily by stimulating insulin release directly. AQ, H2O: aqueous/water extract of the leaf DNC: diabetic negative control rats given only saline GLB: diabetic positive control rats given 5 mg/kg of glibenclamide (a standard antidiabetic agent) HEPES: N-(2-hydroxylethyl)piperazine-N’-2-ethanesulphonic acid HPLC: high pressure liquid chromatography INS-1: rat insulinoma cell line (insulin secreting cell line) KRBH: Krebs-Ringer-bicarbonate buffer with HEPES NGR: normoglycaemic control rats given only saline RPMI medium: Roswell Park Memorial Institute medium SCA, EtOAc: ethyl acetate partition fraction of SCM SCB, BuOH: butanol partition fraction of SCM SCM, MeOH: methanolic extract of the leaf SCW, H2O: aqueous/water partition fraction of SCM TLC: thin layer chromatography To: Time (0 h) of administration of the extract/fraction/drug Tt: 1, 2 and 4 h after administration of the extract/fraction/drug VLC: vacuum liquid chromatography
Various combinations of Nauclea latifolia root, Artocarpus altilis stem bark, Murraya koenigii leaf and Enantia chlorantha stem bark used in African ethnomedicine as decoctions for malaria and fevers,and combinations with standard drugs, were investigated for antiplasmodial activities using Plasmodium berghei berghei-infected mice. The respective prophylactic and curative ED50 values of 189.4 and 174.5 mg/kg for N. latifolia and chemosuppressive ED50 value of 227.2 mg/kg for A. altilis showed that they were the best antimalarial herbal drugs. A 1.6-fold increase of the survival time given by the negative control was elicited by M. koenigii, thereby confirming its curative activity. Pyrimethamine with an ED50 of 0.5 ± 0.1 mg/kg for the prophylactic, and chloroquine with ED50 = 2.2 ± 0.1 and 2.2 ± 0.0 mg/kg for the chemosuppressive and curative tests, respectively, were significantly (p < 0.05) more active. Co-administrations of N. latifolia with the standard drugs significantly reduced their prophylactic, chemosuppressive and curative actions, possibly increasing the parasites’ resistance. Binary combinations of N. latifolia or M. koenigii with any of the other plants significantly increased the prophylactic and suppressive activities of their individual plants, respectively. Also, E. chlorantha with A. altilis or N. latifolia enhanced their respective prophylactic or curative activities, making these combinations most beneficial against malaria infections. Combinations of three and four extracts gave varied activities. Hence, the results justified the combinations of ethnomedicinal plants in antimalarial herbal remedies and showed the importance of the three in vivo models in establishing antimalarial activity.
Aedes aegypti is the primary vector of chikungunya, yellow and dengue fevers. Dengue fever is the major cause of child morbidity and hospitalisation in some Asian and African countries, while yellow fever is prevalent in Nigeria. The development of resistance to the available insecticides has necessitated the continued search for safer ones from plants. Eighteen plant extracts with ethnomedical claims of or demonstrated febrifuge, antimalarial, insecticidal and insect repellent biological activities were tested for activity against the fourth instar larvae of Aedes aegypti. About 61% of the eighteen extracts demonstrated high to moderate larvicidal activity. Extracts of Piper nigrum and Abrus precatorius seeds were the most active and the larvicidal constituent(s) of the latter should be determined.